This excerpt taken from the ARCC 8-K filed Jul 11, 2008.
Vantage Oncology, Inc., headquartered in Manhattan Beach, CA, acquires, joint ventures, develops and operates radiation oncology centers of excellence. The Company has developed a geographically diverse set of centers and now operates in 10 regions which include the Santa Clarita and San Fernando Valleys in Southern California; the Inland Empire in Southern California; Central Texas; Chicago, Illinois; Evansville, Indiana; Cincinnati, Ohio; New York City; Eastern Pennsylvania; Central Florida; and Southern New England (Boston and Providence). The Companys 31 centers currently provide over 200,000 patient treatments annually, including conventional, IMRT, IGRT, SRS and brachytherapy treatments. Vantage also provides medical physics services to its own centers as well as independent hospital and physician clients through its subsidiary, Vantage Oncology Physics, and provides billing services through its subsidiary, Vantage Medical Management Services. Vantages equity investors include: New Enterprise Associates (NEA), CCP Equity Partners, Versant Ventures, Salix Ventures and Camden Partners.
ABOUT ARES CAPITAL CORPORATION
Ares Capital Corporation is a specialty finance company that is a closed-end, non-diversified management investment company. Ares Capital Corporation has elected to be regulated as a business development company under the Investment Company Act of 1940. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. Ares Capital Corporation invests primarily in first and second lien senior loans and mezzanine debt, which in some cases includes an equity component, and, to a lesser extent, in equity investments in private U.S. middle market companies.